Sage Therapeutics Ownership | Who Owns Sage Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Sage Therapeutics Ownership Summary

Sage Therapeutics is owned by 78.03% institutional investors, 10.36% insiders, and 11.60% retail investors. Blackrock is the largest institutional shareholder, holding 8.67% of SAGE shares. BB Biotech AG Ord is the top mutual fund, with 7.29% of its assets in Sage Therapeutics shares.

SAGE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Sage Therapeutics	78.03%	10.36%	11.60%
Sector	Healthcare Stocks	488.30%	11.08%	-399.38%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	5.22M	8.67%	$56.64M
Vanguard group	4.84M	7.92%	$26.27M
Blackrock funding, inc. /de	4.55M	7.26%	$41.45M
Madison avenue partners, lp	4.48M	7.24%	$35.60M
Fmr	4.12M	6.74%	$22.36M
Hudson bay capital management lp	1.95M	3.12%	$17.80M
Acadian asset management	1.59M	2.59%	$8.60M
Balyasny asset management	1.52M	2.42%	$13.85M
Jacobs levy equity management	1.43M	2.37%	$15.48M
Morgan stanley	1.39M	2.31%	$15.10M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Harvest management	889.20K	3.45%	$8.11M
Madison avenue partners, lp	4.48M	3.02%	$35.60M
Bck capital management lp	297.04K	2.34%	$2.71M
Adar1 capital management	721.60K	1.01%	$6.58M
Newtyn management	700.00K	0.97%	$6.38M
683 capital management	1.15M	0.69%	$10.49M
Bardin hill management partners lp	121.52K	0.65%	$1.11M
Alpine associates management	1.27M	0.62%	$11.61M
Cannon global investment management	32.50K	0.61%	$296.40K
Monaco asset management sam	366.62K	0.59%	$3.34M

Top Buyers

Holder	Shares	% Assets	Change
Madison avenue partners, lp	4.48M	3.02%	4.48M
Balyasny asset management	1.52M	0.02%	1.40M
Hudson bay capital management lp	1.95M	0.06%	1.37M
Alpine associates management	1.27M	0.62%	1.27M
Toronto dominion bank	1.08M	0.02%	1.08M

Top Sellers

Holder	Shares	% Assets	Change
Wellington management group llp	39.65K	0.00%	-4.71M
Bellevue group	-	-	-4.46M
Caligan partners lp	-	-	-3.05M
Rtw investments, lp	-	-	-3.00M
Tig advisors	83.20K	0.04%	-2.65M

New Positions

Holder	Shares	% Assets	Change	Value
Madison avenue partners, lp	4.48M	3.02%	4.48M	$35.60M
Alpine associates management	1.27M	0.62%	1.27M	$11.61M
Qube research	1.08M	0.01%	1.08M	$9.87M
Newtyn management	700.00K	0.97%	700.00K	$6.38M
Glazer capital	441.11K	0.14%	441.11K	$4.02M

Sold Out

Holder	Change
Ronald blue trust	-2.00
Dinuzzo private wealth	-5.00
Org partners	-5.00
Principal securities	-6.00
Jfs wealth advisors	-8.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	203	-0.98%	48,858,145	-5.59%	78	1.11%	95	-13.64%	57	7.55%
Mar 31, 2025	16	-91.26%	11,920,805	-76.73%	19	0.27%	11	-85.71%	3	-94.83%
Dec 31, 2024	180	-2.70%	51,167,968	-0.51%	83	1.18%	75	-6.25%	59	15.69%
Sep 30, 2024	185	-8.87%	51,430,442	-3.85%	84	1.06%	81	-25.69%	51	-3.77%
Jun 30, 2024	200	-5.21%	53,449,131	-8.16%	88	0.94%	106	9.28%	53	-8.62%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
BB Biotech AG Ord	4.46M	7.29%	-
Fidelity Growth Compy Commingled Pl O	2.39M	3.91%	-
Vanguard Total Stock Mkt Idx Inv	1.82M	2.90%	-
Vanguard US Total Market Shares ETF	1.71M	2.78%	-
SPDR® S&P Biotech ETF	1.63M	2.66%	23.14K
iShares Russell 2000 ETF	1.42M	2.27%	9.88K
Vanguard Strategic Equity Inv	1.07M	1.71%	412.85K
Vanguard Institutional Extnd Mkt Idx Tr	861.90K	1.37%	-19.18K
Fidelity Growth Compy Commingled Pl S	756.86K	1.23%	-1.27M
Merchfondo FI	746.50K	1.21%	-233.50K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 09, 2023	Barrett Elizabeth	-	Buy	$37.28K
May 09, 2023	Barrett Elizabeth	-	Buy	$50.50K
Feb 10, 2023	JONAS JEFFREY M	-	Sell	$347.08K
Feb 10, 2023	JONAS JEFFREY M	-	Sell	$172.33K
Nov 10, 2022	Greene Barry E	President and CEO	Buy	$500.02K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-

SAGE Ownership FAQ

Who Owns Sage Therapeutics?

Sage Therapeutics shareholders are primarily institutional investors at 78.03%, followed by 10.36% insiders and 11.61% retail investors. The average institutional ownership in Sage Therapeutics's industry, Biotech Stocks , is 307.10%, which Sage Therapeutics falls below.

Who owns the most shares of Sage Therapeutics?

Sage Therapeutics’s largest shareholders are Blackrock (5.22M shares, 8.67%), Vanguard group (4.84M shares, 7.92%), and Blackrock funding, inc. /de (4.55M shares, 7.26%). Together, they hold 23.85% of Sage Therapeutics’s total shares outstanding.

Does Blackrock own Sage Therapeutics?

Yes, BlackRock owns 8.67% of Sage Therapeutics, totaling 5.22M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 56.64M$. In the last quarter, BlackRock increased its holdings by 323.43K shares, a 6.61% change.

Who is Sage Therapeutics’s biggest shareholder by percentage of total assets invested?

Harvest management is Sage Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.45% of its assets in 889.2K Sage Therapeutics shares, valued at 8.11M$.

Who is the top mutual fund holder of Sage Therapeutics shares?

BB Biotech AG Ord is the top mutual fund holder of Sage Therapeutics shares, with 7.29% of its total shares outstanding invested in 4.46M Sage Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools